AFT Pharmaceuticals

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
AFT Pharma is headquartered in Australasia and has out-licensing agreements in over 125 countries around the world in addition to local sales in Australia and New Zealand.
AFT Pharma has developed a portfolio of proprietary analgesics featuring oral dose forms [tablets, oral liquid, powder sachets, rapid release, cold & flu] and intravenous. The advantage is a high level of efficacy whilst being opioid free.
Further developments are underway using proprietary drug delivery technologies
Ticker:
AFT
Exchange:
NZX
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
New Zealand
Year Founded:
1997
Main Therapeutic Focus:
Lead Product in Development:
Maxigesic
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
CEO and Founder
AFT Pharmaceuticals